@Article{,
AUTHOR = {Richard W. Casey, Jack Barkin},
TITLE = {Testosterone replacement therapy for the  primary care physician},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {15},
YEAR = {2008},
NUMBER = {Suppl.4},
PAGES = {71--77},
URL = {http://www.techscience.com/CJU/v15nSuppl.4/63117},
ISSN = {1488-5581},
ABSTRACT = {Testosterone replacement therapy (TRT) can have 
signifi cant benefi cial effects in the appropriate hypogonadal 
male patient. Testosterone defi ciency is common in primary 
care practice and recognition of the signs and symptoms of 
this abnormality will allow physicians to choose appropriate 
interventions. The symptoms of clinical hypogonadism 
include muscle weakness, fatigue, mood changes and a 
reduced libido. Signs include a reduced muscle mass, 
osteoporosis, anemia and increased adiposity. <br/>
While routine screening for testosterone defi ciency, 
determination of testosterone levels in high risk 
populations, including obesity and diabetes, will help 
the clinician direct TRT to the patients most likely 
to benefi t from therapy. In this article the syndrome 
of male hypogonadism is discussed, together with 
therapeutic choices available to the primary care 
physician.},
DOI = {}
}